secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001171843-23-003943
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Compass Therapeutics announces results of 2023 annual meeting of stockholders
-----------------------------------------------------------------------------

- Elected Thomas J Schuetz and Richard S Lindahl as Class III directors for three-year terms.
- Schuetz: 67,240,784 for, 17,368,756 withheld; Lindahl: 84,596,658 for, 12,882 withheld.
- Ratified CohnReznick LLP as independent auditor for 2023: 96,574,239 for, 130,740 against, 24,542 abstained.
- Broker non-votes: 12,119,981 on director election; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000117184323003943/0001171843-23-003943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000117184323003943/f8k_061523.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-003943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer